These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 22605820
1. Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates. Uña E. BMJ Case Rep; 2012 Mar 27; 2012():. PubMed ID: 22605820 [Abstract] [Full Text] [Related]
2. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620 [Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Van Poznak C, Estilo C. Oncology (Williston Park); 2006 Aug 01; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349 [Abstract] [Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children? Brown JJ, Ramalingam L, Zacharin MR. Clin Endocrinol (Oxf); 2008 Jun 01; 68(6):863-7. PubMed ID: 18221397 [Abstract] [Full Text] [Related]
18. Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab. Ngamphaiboon N, Frustino JL, Kossoff EB, Sullivan MA, O'Connor TL. Clin Breast Cancer; 2011 Aug 01; 11(4):252-7. PubMed ID: 21729657 [Abstract] [Full Text] [Related]